CHICAGO, October 08, 2025--(BUSINESS WIRE)--Emalex Biosciences today announced that the U.S. Food and Drug Administration has authorized the company’s Expanded Access Program (EAP) for ecopipam, an ...
First physician enrolled in access program for Rhythm’s ColoSTAT blood test to detect bowel cancer Program marks ColoSTAT’s entry into structured commercial deployment and Rhythm’s first pathway to ...
SAN DIEGO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (aTyr or the Company), a clinical stage biotechnology company engaged in the discovery and development of first-in-class ...
Baylor selects the Nautilus Voyager™ Platform, now available through Early Access Program, for development of a first-in-class computational multi-omics toolkit ...
Cognition Therapeutics, Inc. announced the initiation of an expanded access program (EAP) funded by an anonymous philanthropic donation from the family of a patient with dementia with Lewy bodies (DLB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results